Navigation Links
Cumberland Pharmaceuticals Reports 2012 Annual Financial Results
Date:2/28/2013

alization of Caldolor in those countries.

Company UpdateIn November 2012, Cumberland completed a realignment of its national sales organization to more efficiently cover key targets in support of all three marketed products, Caldolor, Acetadote and Kristalose, in the United States.

Conference Call and WebcastA conference call and live Internet webcast will be held on Thursday, February 28, 2013 at 4:30 p.m. Eastern Time to discuss the Company's fourth quarter 2012 financial results. To participate in the call, please dial 877-303-1298 (for U.S. callers) or 253-237-1032 (for international callers). A rebroadcast of the teleconference will be available for one week and can be accessed by dialing 855-859-2056 (for U.S. callers) or 404-537-3406 (for international callers). The Conference ID for the rebroadcast is 97366269. The live webcast and rebroadcast can be accessed via Cumberland's website at http://investor.shareholder.com/cpix/events.cfm.

About Cumberland PharmaceuticalsCumberland Pharmaceuticals Inc. is a specialty pharmaceutical company focused on the acquisition, development and commercialization of branded prescription products. The Company's primary target markets include hospital acute care and gastroenterology. Cumberland's marketed products include Acetadote® (acetylcysteine) Injection for the treatment of acetaminophen poisoning, Caldolor® (ibuprofen) Injection, the first injectable treatment for pain and fever approved in the United States, and Kristalose® (lactulose) for Oral Solution, a prescription laxative. Cumberland is dedicated to providing innovative products that improve quality of care for patients. For more information, please visit the Company's website at www.cumberlandpharma.com.  

About AcetadoteAcetadote, administered intravenously within 8 to 10 ho
'/>"/>

SOURCE Cumberland Pharmaceuticals Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11

Related medicine technology :

1. Cumberland Pharmaceuticals Reports First Quarter 2012 Financial Results
2. Cumberland Pharmaceuticals To Present At The 2012 Wells Fargo Securities Healthcare Conference In Boston
3. Cumberland Pharmaceuticals To Announce Second Quarter 2012 Financial Results On August 2, 2012
4. Cumberland Pharmaceuticals Reports Second Quarter 2012 Financial Results
5. Cumberland Pharmaceuticals to Present at the UBS Global Life Sciences Conference in New York
6. Cumberland Pharmaceuticals Reports Third Quarter 2012 Financial Results
7. Cumberland Emerging Technologies Expands Life Sciences Center
8. Cumberland Pharmaceuticals And PT. SOHO Industri Pharmasi enter Into Exclusive Licensing Agreement For Caldolor In Indonesia
9. Cumberland Pharmaceuticals To Announce 2012 Year End Financial Results On February 28, 2013
10. Savient Pharmaceuticals to Hold First Quarter 2012 Financial Results Conference Call on Wednesday, May 9, 2012
11. Auxilium Pharmaceuticals to Present at the Deutsche Bank 37th Annual Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/27/2015)... HOUSTON, TX , Feb. 27, 2015 /PRNewswire/ ... and Bloom Burton & Co. Ltd. ("Bloom Burton") today ... (the "Lock-Up") 2,353,130 common shares of the Company ("Common ... to the Lock-Up. Of the Common Shares released from ... upon release from the Lock-Up while the remainder will ...
(Date:2/27/2015)... Report Details   ... R&D progress, and predicted revenues ,Where is the market ... commercial prospects for this market and related technologies? Visiongain,s ... trends to 2025, discussing data, opportunities and prospects. ... regenerative medicine : cell-based therapies that aim to restore ...
(Date:2/27/2015)... 27, 2015 /CNW/ - Covalon Technologies Ltd. (the "Company" or ... announced financial results for its first quarter ended December ... ended December 31, 2014, revenue was $1,336,685. Operating expenses ... or $0.02 per share.  Covalon,s President ... very pleased with the significant progress we have made ...
Breaking Medicine Technology:ESSA Pharma and Bloom Burton announce additional release of shares from voluntary lock-up agreement 2ESSA Pharma and Bloom Burton announce additional release of shares from voluntary lock-up agreement 3ESSA Pharma and Bloom Burton announce additional release of shares from voluntary lock-up agreement 4Translational Regenerative Medicine: Market Prospects 2015-2025 2Translational Regenerative Medicine: Market Prospects 2015-2025 3Translational Regenerative Medicine: Market Prospects 2015-2025 4Translational Regenerative Medicine: Market Prospects 2015-2025 5Translational Regenerative Medicine: Market Prospects 2015-2025 6Translational Regenerative Medicine: Market Prospects 2015-2025 7Translational Regenerative Medicine: Market Prospects 2015-2025 8Covalon Announces First Quarter Financial Results 2Covalon Announces First Quarter Financial Results 3
... DIEGO, Dec. 22, 2011 ViroPharma Incorporated (NASDAQ: ... exclusive option to acquire Meritage Pharma, Inc., a private company ... suspension (OBS) as a treatment for eosinophilic esophagitis (EoE), a ... has paid an initial $7.5 million, and has agreed to ...
... Therapeutics, Inc. (Nasdaq: OREX ) today announced the ... consisted of one share of common stock and a warrant ... to the public of $1.45 per share of common stock ... stock, which together comprised the purchase price of $15.94 per ...
Cached Medicine Technology:ViroPharma Purchases Exclusive Option to Acquire Meritage Pharma 2ViroPharma Purchases Exclusive Option to Acquire Meritage Pharma 3ViroPharma Purchases Exclusive Option to Acquire Meritage Pharma 4ViroPharma Purchases Exclusive Option to Acquire Meritage Pharma 5ViroPharma Purchases Exclusive Option to Acquire Meritage Pharma 6ViroPharma Purchases Exclusive Option to Acquire Meritage Pharma 7Orexigen® Therapeutics Completes Public Offering of Common Stock and Warrants to Purchase Common Stock 2
(Date:2/27/2015)... NY (PRWEB) February 27, 2015 In ... to the community by providing free dental care from ... has partnered with Dentistry from the Heart, and ... 11, 2015. The first 50 patients who are in ... they can’t afford, will have access to high­quality service ...
(Date:2/27/2015)... 2015 The federal court overseeing more ... use of the statin medication can increase a person’s ... new order pertaining discovery in the cases selected for ... comments. The Order, which was issued in the U.S. ... directs the parties to schedule certain witness depositions before ...
(Date:2/27/2015)... February 27, 2015 According to court ... Hospital on June 25, 2013 and underwent a procedure ... through her mouth. Because the duodenoscope allegedly had ... the antibiotic-resistant “superbug” carbapenem-resistant Enterobacteriaceae (CRE). , ... of Cook County on behalf of Ms. Pirolli alleging ...
(Date:2/27/2015)... FL (PRWEB) February 27, 2015 ... companies, devices and pharmaceuticals, Benedict Advertising & Marketing ... its newest client. The company’s patented NITROUSEAL® N20 ... pain-free, no-stress method of sedation. , Sedation Systems, ... patient comfort to a new level, though it ...
(Date:2/27/2015)... The Dawn Greene Hospice, a 10-bed facility located on ... the Upper East Side, was officially dedicated and blessed at ... Timothy Michael Cardinal Dolan. , Thomas J. Fahey, Jr., MD, ... member of the ArchCare Board of Trustees, presided over the ... director of MMW, and Christina McInerney, president and CEO of ...
Breaking Medicine News(10 mins):Health News:Dr. Umanoff Unites with Dentistry from the Heart to Provide Community with Charitable Dental Care 2Health News:Dr. Umanoff Unites with Dentistry from the Heart to Provide Community with Charitable Dental Care 3Health News:Federal Lipitor Litigation Issues New Order Pertaining to Discovery in Bellwether Cases, Bernstein Liebhard LLP Comments 2Health News:Federal Lipitor Litigation Issues New Order Pertaining to Discovery in Bellwether Cases, Bernstein Liebhard LLP Comments 3Health News:Lawsuit Alleges Blame on Scope Manufacturer for "Superbug" Outbreak 2Health News:Benedict Advertising & Marketing Signs Sedation Systems 2Health News:The Dawn Greene Hospice Is Officially Dedicated 2Health News:The Dawn Greene Hospice Is Officially Dedicated 3
... Biology MeetingNEW ORLEANS, April 20 Research presented today ... lower cholesterol by 10 percent in one month. The ... Research, found that eating two 1 1/2 cup servings ... diet low in fat, lowered LDL or "bad" cholesterol ...
... longer, study suggests, , , MONDAY, April 20 (HealthDay News) -- Want ... how to manage your stress. , A new study found that ... lived to 100, and longevity is thought to run in families. ... traits that set the children of centenarians apart from other people ...
... Who better to provide healthy eating tips than ... Cardiovascular and Wellness Nutrition (SCAN) Dietetic Practice Group of ... the Great Tomato Tip-Off Contest!, a partnership effort between ... encouraged dietitians to send in their best tips for ...
... Scientists Discover Eating Cherries May Elevate Antioxidant Activity in ... and a half servings of tart cherries could significantly ... University of Michigan research reported at the ... study, healthy adults who ate a cup and a ...
... April 20 /PRNewswire-FirstCall/ - Response Biomedical Corporation (TSX: ... for the three-month period ended March 31, 2009. ... million compared to $1.173 million for the same ... for any quarter in the Company,s history and, ...
... Tenn., April 20 HCA Healthcare announces the following Webcast: What: ... 27, 2009 @ 10:00 EST , Where: ... the Internet -- Simply log on to the web , ... Contact: Mark Kimbrough, Investor Relations at HCA Healthcare, , ...
Cached Medicine News:Health News:Cheerios(R) Can Help Reduce Cholesterol 10 Percent in One Month 2Health News:Cheerios(R) Can Help Reduce Cholesterol 10 Percent in One Month 3Health News:Outgoing Nature Could Get You to 100 2Health News:Outgoing Nature Could Get You to 100 3Health News:The Tomato Products Wellness Council and SCAN Announce Winners for the Great Tomato Tip-Off Contest! 2Health News:The Tomato Products Wellness Council and SCAN Announce Winners for the Great Tomato Tip-Off Contest! 3Health News:New Human Study Reinforces Antioxidant Benefits of Tart Cherries 2Health News:New Human Study Reinforces Antioxidant Benefits of Tart Cherries 3Health News:Response Biomedical Corporation Delivers Record Preliminary Revenues in First Quarter 2Health News:Response Biomedical Corporation Delivers Record Preliminary Revenues in First Quarter 3Health News:Response Biomedical Corporation Delivers Record Preliminary Revenues in First Quarter 4
1.7/2.2 mm Delta System resorbable implant technology merges science and simplicity for a superior craniomaxillofacial surgery product. The system consists of resorbable bone plates and screws fabric...
... A-scan Sonomed-315 is intended for visualization of ... of midline shifts in the brain, evaluation ... easy to use, the Sonomed-315 offers quick ... mode allows to identify the anatomic structures ...
... a scaleable device that works ... platelet plasma or buffy coat. ... coat must be prepared independently ... Starting volume and concentration factor ...
The Ultrafoam Collagen Sponge is indicated in all surgical procedures as an adjunct to hemostasis when control by ligature or conventional procedures are ineffective or impractical....
Medicine Products: